Gilbert J. Rahme
Gilbert J. Rahme
Postdoctoral Research Fellow, Massachusetts General Hospital and the Broad Institute
Verified email at mgh.harvard.edu
TitleCited byYear
Splice variant–specific cellular function of the formin INF2 in maintenance of Golgi architecture
V Ramabhadran, F Korobova, GJ Rahme, HN Higgs
Molecular biology of the cell 22 (24), 4822-4833, 2011
592011
Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma
P Mao, MP Hever-Jardine, GJ Rahme, E Yang, J Tam, A Kodali, B Biswal, ...
PLoS One 8 (11), e81803, 2013
562013
Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function
GJ Rahme, MA Israel
Oncogene 34 (1), 53, 2015
452015
Context dependent reversion of tumor phenotype by connexin-43 expression in MDA-MB231 cells and MCF-7 cells: Role of β-catenin/connexin43 association
RS Talhouk, MB Fares, GJ Rahme, HH Hariri, T Rayess, HA Dbouk, ...
Experimental cell research 319 (20), 3065-3080, 2013
382013
Regulatory T cells are not a strong predictor of survival for patients with glioblastoma
AA Thomas, JL Fisher, GJ Rahme, TH Hampton, U Baron, S Olek, ...
Neuro-oncology 17 (6), 801-809, 2015
292015
PDGF engages an E2F-USP1 signaling pathway to support ID2-mediated survival of proneural glioma cells
GJ Rahme, Z Zhang, AL Young, C Cheng, EJ Bivona, SN Fiering, ...
Cancer research 76 (10), 2964-2976, 2016
212016
An integrative model of cellular states, plasticity, and genetics for glioblastoma
C Neftel, J Laffy, MG Filbin, T Hara, ME Shore, GJ Rahme, AR Richman, ...
Cell 178 (4), 835-849. e21, 2019
142019
Pediatric brain tumors: current knowledge and therapeutic opportunities
J Glod, GJ Rahme, H Kaur, E Raabe, EI Hwang, MA Israel
Journal of pediatric hematology/oncology 38 (4), 249, 2016
122016
Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma
AA Thomas, JL Fisher, TH Hampton, BC Christensen, GJ Tsongalis, ...
Cancer Immunology, Immunotherapy 66 (3), 379-389, 2017
102017
MiR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation
JRH VI, ES Li, SE Streeter, GJ Rahme, E Chipumuro, GB Russo, JF Litzky, ...
PloS one 12 (5), e0177661, 2017
82017
ID2 promotes survival of glioblastoma cells during metabolic stress by regulating mitochondrial function
Z Zhang, GJ Rahme, PD Chatterjee, MC Havrda, MA Israel
Cell death & disease 8 (2), e2615, 2017
82017
A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma
GJ Rahme, BW Luikart, C Cheng, MA Israel
Neuro-oncology 20 (3), 332-342, 2017
42017
Gap junctions mediate STAT5-independent β-casein expression in CID-9 mammary epithelial cells
RS Talhouk, AA Khalil, R Bajjani, GJ Rahme, ME El-Sabban
Cell communication & adhesion 18 (5), 104-116, 2011
32011
Brain Tumors
S Kesari, GJ Rahme, DA Almiron, MA Israel
Schwab 5, 16, 2016
1*2016
STK17A is a potential therapeutic target in glioblastoma
P Mao, MP Jardine, GJ Rahme, EC Yang, J Tam, A Kodali, B Biswal, ...
Cancer Research 74 (19 Supplement), 4605-4605, 2014
12014
GABPβ1L Wakes Up TERT
GJ Rahme, E Gaskell, BE Bernstein
Cancer cell 34 (3), 358-360, 2018
2018
Identifying Critical Signaling Pathways Underlying Glioblastoma Pathology
GJ Rahme
Dartmouth College, 2017
2017
PDGF signaling maintains survival of proneural glioma cells by regulating USP1 to stabilize ID2
GJ Rahme, Z Zhang, AL Young, C Cheng, EJ Bivona, SN Fiering, ...
Cancer Research 76 (14 Supplement), 1891-1891, 2016
2016
Id4 inhibition of twist1-mediated autocrine PDGF signaling inhibits growth and promotes apoptosis of glioblastoma-derived stem cell cultures
GJ Rahme, MA Israel
Cancer Research 74 (19 Supplement), 210-210, 2014
2014
Inhibitor of DNA binding 4 (Id4) suppresses MMP2 mediated invasion of glioblastoma-derived cells by direct inactivation of twist-1 function.
GJ Rahme, MA Israel
Cancer Research 73 (8 Supplement), 4931-4931, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20